Non-Coding RNAs as Blood-Based Biomarkers in Cardiovascular Disease
- PMID: 33291434
- PMCID: PMC7730567
- DOI: 10.3390/ijms21239285
Non-Coding RNAs as Blood-Based Biomarkers in Cardiovascular Disease
Abstract
In 2020, cardiovascular diseases (CVDs) remain a leading cause of mortality and morbidity, contributing to the burden of the already overloaded health system. Late or incorrect diagnosis of patients with CVDs compromises treatment efficiency and patient's outcome. Diagnosis of CVDs could be facilitated by detection of blood-based biomarkers that reliably reflect the current condition of the heart. In the last decade, non-coding RNAs (ncRNAs) present on human biofluids including serum, plasma, and blood have been reported as potential biomarkers for CVDs. This paper reviews recent studies that focus on the use of ncRNAs as biomarkers of CVDs.
Keywords: biomarkers; cardiovascular diseases; diagnosis; ncRNAs.
Conflict of interest statement
P.A.d.C.M. is a cofounder of Mirabilis Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Circulating Non-coding RNAs and Cardiovascular Diseases.Adv Exp Med Biol. 2020;1229:357-367. doi: 10.1007/978-981-15-1671-9_22. Adv Exp Med Biol. 2020. PMID: 32285424 Review.
-
Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.Circ Res. 2017 Jan 20;120(2):381-399. doi: 10.1161/CIRCRESAHA.116.308434. Circ Res. 2017. PMID: 28104771 Review.
-
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.Eur Heart J. 2018 Aug 1;39(29):2704-2716. doi: 10.1093/eurheartj/ehx165. Eur Heart J. 2018. PMID: 28430919 Free PMC article. Review.
-
Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.Brief Bioinform. 2019 Jan 18;20(1):66-76. doi: 10.1093/bib/bbx095. Brief Bioinform. 2019. PMID: 28968629
-
Clinical utility of circulating non-coding RNAs - an update.Nat Rev Clin Oncol. 2018 Sep;15(9):541-563. doi: 10.1038/s41571-018-0035-x. Nat Rev Clin Oncol. 2018. PMID: 29784926 Review.
Cited by
-
Association between HOTAIR lncRNA Polymorphisms and Coronary Artery Disease Susceptibility.J Pers Med. 2021 May 4;11(5):375. doi: 10.3390/jpm11050375. J Pers Med. 2021. PMID: 34064346 Free PMC article.
-
Role of ncRNAs in the Development of Chronic Pain.Noncoding RNA. 2025 Jul 3;11(4):51. doi: 10.3390/ncrna11040051. Noncoding RNA. 2025. PMID: 40700093 Free PMC article. Review.
-
Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2022 Sep 15;9:1029-1040. doi: 10.2147/JHC.S380237. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 36132427 Free PMC article. Review.
-
Roles of Long Non-Coding RNAs in the Pathogenesis of Cardiovascular Disorders: Challenges and Opportunities.J Cardiovasc Transl Res. 2025 Aug 18. doi: 10.1007/s12265-025-10675-2. Online ahead of print. J Cardiovasc Transl Res. 2025. PMID: 40825915 Review.
-
The critical role of epigenetic mechanism in PM2.5-induced cardiovascular diseases.Genes Environ. 2021 Oct 15;43(1):47. doi: 10.1186/s41021-021-00219-w. Genes Environ. 2021. PMID: 34654488 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources